Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Smit

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
British Journal of Pharmacology|September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3D J Scholten, M Canals, M Wijtmans, et al.
British Journal of Pharmacology|November 6, 2012
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKRJ Vinet, M van Zwam, I M Dijkstra, et al.
European Journal of Medicinal Chemistry|November 27, 2018
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonistsI Adlere, S Sun, A Zarca, et al.
BMC Medicine|April 22, 2024
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trialM Alkema, M J Smit, C Marin-Mogollon, et al.
British Journal of Pharmacology|November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexesA O Watts, M M H van Lipzig, W C Jaeger, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
British Journal of Pharmacology|September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3D J Scholten, M Canals, M Wijtmans, et al.
British Journal of Pharmacology|November 6, 2012
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKRJ Vinet, M van Zwam, I M Dijkstra, et al.
European Journal of Medicinal Chemistry|November 27, 2018
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonistsI Adlere, S Sun, A Zarca, et al.
BMC Medicine|April 22, 2024
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trialM Alkema, M J Smit, C Marin-Mogollon, et al.
British Journal of Pharmacology|November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexesA O Watts, M M H van Lipzig, W C Jaeger, et al.
Pageof 10